Jennifer N. Clements Pharm.D., FCCP, Katie McClendon Pharm.D., FCCP, Jill Borchert Pharm.D., FCCP, Stephanie R. L. Ciapala Pharm.D., Lindsay A. Courtney Pharm.D., Jamessa Cummings Pharm.D., Julianne M. Fallon Pharm.D., Megan Kunka Fritz Pharm.D., Caitlin M. Gibson Pharm.D., MEd, Alex N. Isaacs Pharm.D., M.S., Emily N. Israel Pharm.D., Peter Johnson Pharm.D., Abby Krauter Pharm.D., Aubrey R. Stolte
Postgraduate pharmacy residencies equip trainees with advanced clinical skills for patient care and prepare them for specialized roles in their careers. Teaching is a core responsibility for most pharmacists, yet postgraduate residency training often lacks standardization in teaching and learning experiences. The American Society of Health-System Pharmacists (ASHP) provides residency accreditation standards; however, the activities related to teaching objectives may lack consistency across institutions and programs. The 2024 American College of Clinical Pharmacy (ACCP) Publications Committee updated a previous publication on standardized teaching experiences for all residencies and programs offering a teaching certificate or other teaching experiences. The current paper highlights information and activities for residency programs to promote diverse teaching experiences, including the introduction of a tier system. Postgraduate pharmacy residencies should adopt these guidelines to offer consistent teaching experiences with personalization for trainees. Residents should also inquire about the teaching components of programs to choose the best fit for their career goals. There should be a balance between standardization and flexibility in teaching experiences to prepare residents for diverse roles in clinical practice or academia.
{"title":"Teaching experiences in pharmacy residency","authors":"Jennifer N. Clements Pharm.D., FCCP, Katie McClendon Pharm.D., FCCP, Jill Borchert Pharm.D., FCCP, Stephanie R. L. Ciapala Pharm.D., Lindsay A. Courtney Pharm.D., Jamessa Cummings Pharm.D., Julianne M. Fallon Pharm.D., Megan Kunka Fritz Pharm.D., Caitlin M. Gibson Pharm.D., MEd, Alex N. Isaacs Pharm.D., M.S., Emily N. Israel Pharm.D., Peter Johnson Pharm.D., Abby Krauter Pharm.D., Aubrey R. Stolte","doi":"10.1002/jac5.2066","DOIUrl":"https://doi.org/10.1002/jac5.2066","url":null,"abstract":"<p>Postgraduate pharmacy residencies equip trainees with advanced clinical skills for patient care and prepare them for specialized roles in their careers. Teaching is a core responsibility for most pharmacists, yet postgraduate residency training often lacks standardization in teaching and learning experiences. The American Society of Health-System Pharmacists (ASHP) provides residency accreditation standards; however, the activities related to teaching objectives may lack consistency across institutions and programs. The 2024 American College of Clinical Pharmacy (ACCP) Publications Committee updated a previous publication on standardized teaching experiences for all residencies and programs offering a teaching certificate or other teaching experiences. The current paper highlights information and activities for residency programs to promote diverse teaching experiences, including the introduction of a tier system. Postgraduate pharmacy residencies should adopt these guidelines to offer consistent teaching experiences with personalization for trainees. Residents should also inquire about the teaching components of programs to choose the best fit for their career goals. There should be a balance between standardization and flexibility in teaching experiences to prepare residents for diverse roles in clinical practice or academia.</p>","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"8 1","pages":"62-69"},"PeriodicalIF":1.3,"publicationDate":"2025-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143115727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Not just a collection of papers","authors":"Stuart T. Haines Pharm.D., FCCP","doi":"10.1002/jac5.2065","DOIUrl":"https://doi.org/10.1002/jac5.2065","url":null,"abstract":"","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"8 1","pages":"4-5"},"PeriodicalIF":1.3,"publicationDate":"2025-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143115729","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Comment on “Pharmacists should be held to high standards, not hindered by bright-line rules”","authors":"Alex J. Adams Pharm.D., MPH","doi":"10.1002/jac5.2068","DOIUrl":"https://doi.org/10.1002/jac5.2068","url":null,"abstract":"","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"8 1","pages":"70"},"PeriodicalIF":1.3,"publicationDate":"2025-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143115728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Part I: Case series—Immunizations in older adults","authors":"Christine K. O'Neil Pharm.D., FCCP","doi":"10.1002/jac5.2054","DOIUrl":"https://doi.org/10.1002/jac5.2054","url":null,"abstract":"","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"7 12","pages":"1236-1237"},"PeriodicalIF":1.3,"publicationDate":"2024-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142861386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Part II: Case series-Lyme disease and babesiosis","authors":"Raul A. Santiago Pharm.D.","doi":"10.1002/jac5.2056","DOIUrl":"https://doi.org/10.1002/jac5.2056","url":null,"abstract":"","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"7 12","pages":"1238-1239"},"PeriodicalIF":1.3,"publicationDate":"2024-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142851370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"2024 ACCP Annual Meeting October 12–15, 2024","authors":"","doi":"10.1002/jac5.2045","DOIUrl":"https://doi.org/10.1002/jac5.2045","url":null,"abstract":"","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"7 12","pages":"1245-1340"},"PeriodicalIF":1.3,"publicationDate":"2024-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142851369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Comment on “Connecting medication therapy problems with social determinants of health: A proposed framework”","authors":"Sarah E. Vordenberg Pharm.D., MPH","doi":"10.1002/jac5.2051","DOIUrl":"https://doi.org/10.1002/jac5.2051","url":null,"abstract":"","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"7 12","pages":"1235"},"PeriodicalIF":1.3,"publicationDate":"2024-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142861385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Coming full circle—2nd edition","authors":"Jerry L. Bauman Pharm.D., FCCP","doi":"10.1002/jac5.2055","DOIUrl":"https://doi.org/10.1002/jac5.2055","url":null,"abstract":"","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"7 12","pages":"1146"},"PeriodicalIF":1.3,"publicationDate":"2024-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142861392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Thinking about my heroes: The 2024 Paul F. Parker medal for a lifetime of service to pharmacy","authors":"Judith Jacobi Pharm.D., FCCP","doi":"10.1002/jac5.2053","DOIUrl":"https://doi.org/10.1002/jac5.2053","url":null,"abstract":"","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"7 12","pages":"1144-1145"},"PeriodicalIF":1.3,"publicationDate":"2024-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142861393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jacob T. Brown Pharm.D., M.S., Miki Goldwire M.S., M.A., B.S., Amanda Massmann Pharm.D., Joel Van Heukelom Pharm.D., MBA, Amy Pasternak Pharm.D., Natasha Petry MPH, Courtney Paetznick Pharm.D., Larisa H. Cavallari Pharm.D., FCCP
Pharmacogenomic (PGx) considerations are increasingly influencing health system formularies, prompting Pharmacy and Therapeutics (P&T) committees to integrate genetic insights into their decision-making processes. This can be the case in several clinical scenarios, including (1) Prioritizing the use of lower-cost drugs, where PGx testing is applied to guide the use of lower-cost medications when appropriate, (2) Rescuing medications that are effective in the majority of individuals but were removed from the formulary because of harm in a subset of individuals with a specific phenotype, (3) Improving medication safety by utilizing PGx testing/results to guide initiation of reduced drug doses or use of alternative therapy in patients with at-risk genotypes, and (4) Restricting use of high-cost drugs to individuals most likely to respond based on genotype. The primary objective of this PRN opinion piece is to describe how PGx impacts formulary management, including the challenges and opportunities that arise from precision medicine approaches to prescribing.
{"title":"The impact of pharmacogenomics on a pharmacy and therapeutic committee's formulary system management: An opinion of the pharmacokinetics/pharmacodynamics/pharmacogenomics practice and Research Network for the American College of Clinical Pharmacy","authors":"Jacob T. Brown Pharm.D., M.S., Miki Goldwire M.S., M.A., B.S., Amanda Massmann Pharm.D., Joel Van Heukelom Pharm.D., MBA, Amy Pasternak Pharm.D., Natasha Petry MPH, Courtney Paetznick Pharm.D., Larisa H. Cavallari Pharm.D., FCCP","doi":"10.1002/jac5.2057","DOIUrl":"https://doi.org/10.1002/jac5.2057","url":null,"abstract":"<p>Pharmacogenomic (PGx) considerations are increasingly influencing health system formularies, prompting Pharmacy and Therapeutics (P&T) committees to integrate genetic insights into their decision-making processes. This can be the case in several clinical scenarios, including (1) Prioritizing the use of lower-cost drugs, where PGx testing is applied to guide the use of lower-cost medications when appropriate, (2) Rescuing medications that are effective in the majority of individuals but were removed from the formulary because of harm in a subset of individuals with a specific phenotype, (3) Improving medication safety by utilizing PGx testing/results to guide initiation of reduced drug doses or use of alternative therapy in patients with at-risk genotypes, and (4) Restricting use of high-cost drugs to individuals most likely to respond based on genotype. The primary objective of this PRN opinion piece is to describe how PGx impacts formulary management, including the challenges and opportunities that arise from precision medicine approaches to prescribing.</p>","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"8 1","pages":"52-61"},"PeriodicalIF":1.3,"publicationDate":"2024-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jac5.2057","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143114982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号